Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1971 1
1972 2
1974 2
1975 3
1986 1
1987 2
1988 2
1989 3
1990 4
1991 1
1992 2
1993 6
1994 3
1995 6
1996 6
1997 5
1998 5
1999 9
2000 5
2001 4
2002 10
2003 4
2004 7
2005 11
2006 7
2007 20
2008 18
2009 25
2010 28
2011 23
2012 21
2013 23
2014 15
2015 13
2016 12
2017 26
2018 59
2019 56
2020 43
2021 61
2022 35
2023 36
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

557 results

Results by year

Filters applied: . Clear all
Page 1
Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus.
Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A. Yaribeygi H, et al. Among authors: atkin sl. Oxid Med Cell Longev. 2020 Mar 9;2020:8609213. doi: 10.1155/2020/8609213. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32215179 Free PMC article. Review.
Editorial: Omics Solutions for Endocrine Disorders.
Atkin SL, Halama AM. Atkin SL, et al. Front Endocrinol (Lausanne). 2022 Jun 22;13:948991. doi: 10.3389/fendo.2022.948991. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35813641 Free PMC article. No abstract available.
GLP-1 mimetics and cognition.
Yaribeygi H, Rashidy-Pour A, Atkin SL, Jamialahmadi T, Sahebkar A. Yaribeygi H, et al. Among authors: atkin sl. Life Sci. 2021 Jan 1;264:118645. doi: 10.1016/j.lfs.2020.118645. Epub 2020 Oct 26. Life Sci. 2021. PMID: 33121988 Review.
A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes.
Nauck MA, Petrie JR, Sesti G, Mannucci E, Courrèges JP, Lindegaard ML, Jensen CB, Atkin SL; Study 1821 Investigators. Nauck MA, et al. Among authors: atkin sl. Diabetes Care. 2016 Feb;39(2):231-41. doi: 10.2337/dc15-0165. Epub 2015 Sep 10. Diabetes Care. 2016. PMID: 26358288 Clinical Trial.
Investigating hyponatraemia.
Wakil A, Ng JM, Atkin SL. Wakil A, et al. Among authors: atkin sl. BMJ. 2011 Mar 7;342:d1118. doi: 10.1136/bmj.d1118. BMJ. 2011. PMID: 21382929 No abstract available.
557 results